|
1
|
Sørensen JM: Herb-drug, food-drug,
nutrient-drug, and drug-drug interactions: mechanisms involved and
their medical implications. J Altern Complement Med. 8:293–308.
2002.PubMed/NCBI
|
|
2
|
Pan MH, Lai CS, Dushenkov S and Ho CT:
Modulation of inflammatory genes by natural dietary bioactive
compounds. J Agric Food Chem. 57:4467–4477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pan MH, Ghai G and Ho CT: Food bioactives,
apoptosis, and cancer. Mol Nutr Food Res. 52:43–52. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sarker SD and Nahar L: Natural medicine:
the genus Angelica. Curr Med Chem. 11:1479–1500. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Piersen CE: Phytoestrogens in botanical
dietary supplements: implications for cancer. Integr Cancer Ther.
2:120–138. 2003. View Article : Google Scholar
|
|
6
|
Lopes D and Strobl H: Kolodziejczyk P:
14-Methylpentadecano-15-lactone (muscolide): a new macrocyclic
lactone from the oil of Angelica keiskei L. Chem Biodivers.
1:1880–1887. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sigurdsson S, Ogmundsdottir HM and
Gudbjarnason S: Antitumour activity of Angelica keiskei leaf
extract. In Vivo. 19:191–194. 2005.
|
|
8
|
Sigurdsson S, Ogmundsdottir HM and
Gudbjarnason S: The cytotoxic effect of two chemotypes of essential
oils from the fruits of Angelica keiskei L. Anticancer Res.
25:1877–1880. 2005.PubMed/NCBI
|
|
9
|
Yeh ML, Liu CF, Huang CF and Huang TC:
Hepatoprotective effect of Angelica keiskei in chronically
ethanol-treated mice. Pharmacology. 68:70–73. 2003.
|
|
10
|
Heo JC and Lee SH: Amelioration of
asthmatic-related symptoms by an aqueous extract of Angelica
archangelica L. J Life Sci. 18:1336–1341. 2008. View Article : Google Scholar
|
|
11
|
Tavaszi J, Budai P, Pálovics A and
Kismányoki A: An alternative test battery in detecting ocular
irritancy of agrochemicals. Commun Agric Appl Biol Sci. 73:891–895.
2008.PubMed/NCBI
|
|
12
|
Scott L, Eskes C, Hoffmann S, Adriaens E,
Alepée N, Bufo M, Clothier R, Facchini D, Faller C, Guest R, et al:
A proposed eye irritation testing strategy to reduce and replace in
vivo studies using bottom-up and top-down approaches. Toxicol In
Vitro. 24:1–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Osborne R, Perkins MA and Roberts DA:
Development and intralaboratory evaluation of an in vitro human
cell-based test to aid ocular irritancy assessments. Fundam Appl
Toxicol. 28:139–153. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nigam PK: Adverse reactions to cosmetics
and methods of testing. Indian J Dermatol Venereol Leprol.
75:10–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zimmermann M: Ethical guidelines for
investigations of experimental pain in conscious animals. Pain.
16:109–110. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Draize JH, Woodard G and Calvery HO:
Methods for the study of irritation and toxicity of substances
applied topically to the skin and mucous membranes. J Pharmacol Exp
Ther. 82:377–390. 1944.
|
|
17
|
Aoshima H, Saitoh Y, Ito S, Yamana S and
Miwa N: Safety evaluation of highly purified fullernenes: based on
screening of eye and skin damage. J Toxicol Sci. 34:555–562. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Draize JH: Dermal toxicity. Appraisal of
the Safety of Chemicals in Foods, Drugs and Cosmetics. Association
of Food and Drug Officials of the United States. Texas State
Departmemt of Health; Austin, Texas: pp. 46–59. 1959
|
|
19
|
Heo JC, Park JY, Kwon TK, Chung SK, Kim SU
and Lee SH: Development of high-throughput screening method for
anti-asthmatic agents by food-derived libraries. Korean J Food
Preserv. 12:267–274. 2005.
|
|
20
|
Heo JC, Woo SW, Kweon MA, Park JY, Lee HK,
Son M, Rho JR and Lee SH: Aqueous extract of a seed from
Helianthus annuus alleviates asthmatic symptoms in vivo. Int
J Mol Med. 21:57–61. 2008.
|
|
21
|
Korting HC, Herzinger T, Hartinger A,
Kerscher M, Angerpointner T and Maibach HI: Discrimination of the
irritancy potential of surfactants in vitro by two cytotoxicity
assays using normal human keratinocytes, HaCaT cells and 3T3 mouse
fibroblasts: correlation with in vivo data from a soap chamber
assay. J Dermatol Sci. 7:119–129. 1994. View Article : Google Scholar
|
|
22
|
Tardiff RG, Hubner RP and Graves CG:
Harmonization of thresholds for primary skin irritation from
results of human repeated insult patch tests and laboratory animal
skin irritation tests. J Appl Toxicol. 23:279–281. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Basketter DA and Kimber I: Skin
irritation, false positives and the local lymph node assay: a
guideline issue? Regul Toxicol Pharmacol. 61:137–140. 2011.
View Article : Google Scholar : PubMed/NCBI
|
